# Celecoxib Versus Naproxen for Prevention of Recurrent Ulcer Bleeding in Arthritis Patients

> **NCT00153660** · PHASE3 · COMPLETED · sponsor: **Chinese University of Hong Kong** · enrollment: 514 (actual)

## Conditions studied

- Arthritis
- Cardiovascular Diseases
- Cerebrovascular Disorders

## Interventions

- **DRUG:** Celecoxib(drug)
- **DRUG:** Naproxen(drug)

## Key facts

- **NCT ID:** NCT00153660
- **Lead sponsor:** Chinese University of Hong Kong
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-06
- **Primary completion:** 2014-11
- **Final completion:** 2016-12
- **Target enrollment:** 514 (ACTUAL)
- **Last updated:** 2017-01-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00153660

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00153660, "Celecoxib Versus Naproxen for Prevention of Recurrent Ulcer Bleeding in Arthritis Patients". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT00153660. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*